Czechia
Czech patients face longer waits for innovative drugs as access slips [Advocacy Lab]
Analysis shows Czech patients now wait an average of 659 days for innovative therapies after they are approved at EU level
This browser does not support voice playback. Try Chrome, Edge or Safari.